COMP <GO>
LEXX vs CNSP // RETURN ON INVESTED CAPITAL (ROIC)
Lexaria Bioscience Corp. (NASDAQ) VS. CNS Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: LEXX 2
— CNSP 1
■ METRIC PARITY
LAST: $3.49 (-7.43%) • MKT CAP: $7.4M
roic
-35.00%
LAST: $5.00 (+4.82%) • MKT CAP: $7.3M
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LEXX VS. CNSP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LEXX | CNSP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 52.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 1/9 | +3.00 | LEXX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.6 | 49.3 | -0.70 | CNSP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.4M | $7.3M | $44.5K | LEXX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LEXX REV | CNSP REV | LEXX GROSS % | CNSP GROSS % | LEXX FCF | CNSP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $705.9K | $0 | 98.0% | — | -$10.5M | -$13.8M |
| FY 2024 | $464.3K | $0 | 98.0% | — | -$5.0M | -$17.1M |
| FY 2023 | $226.2K | $0 | — | — | -$5.9M | -$14.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LEXX // BETA —
CNSP // BETA —